Documentos relacionados

1. Surfactante pulmonar exógeno en el tratamiento de la enfermedad de membrana hialina severa: efectos agudos
2. [Exogenous surfactants in neonatology].
3. Multi-centre randomised trial of invasive and less invasive surfactant delivery methods showed similar spirometry results at 5-9 years of age.
4. Lung mechanics and gas exchange in ventilated preterm infants during treatment of hyaline membrane disease with multiple doses of artificial surfactant (Exosurf)
5. Comparison of morbidity and mortality of very low birth weight infants in a Central Hospital in Johannesburg between 2006/2007 and 2013.
6. [Lung morphological changes in premature neonates with hyaline membrane disease due to the use of exogenous surfactants during mechanical ventilation].
7. Review demonstrates that less invasive surfactant administration in preterm neonates leads to fewer complications.
8. [High-frequency oscillatory lung ventilation in complex therapy for congenital pneumonia and hyaline membrane disease in newborns].
9. Outcome of neonates requiring assisted ventilation.
10. Blood metabolomics in infants enrolled in a dose escalation pilot trial of budesonide in surfactant.